Literature DB >> 17042243

Delayed treatment of decompression sickness with short, no-air-break tables: review of 140 cases.

Paul Cianci1, John B Slade.   

Abstract

INTRODUCTION: Most cases of decompression sickness (DCS) in the U.S. are treated with hyperbaric oxygen using U.S. Navy Treatment Tables 5 and 6, although detailed analysis shows that those tables were based on limited data. We reviewed the development of these protocols and offer an alternative treatment table more suitable for monoplace chambers that has proven effective in the treatment of DCS in patients presenting to our facility.
METHODS: We reviewed the outcomes for 140 cases of DCS in civilian divers treated with the shorter tables at our facility from January 1983 through December 2002.
RESULTS: Onset of symptoms averaged 9.3 h after surfacing. At presentation, 44% of the patients demonstrated mental aberration. The average delay from onset of symptoms to treatment was 93.5 h; median delay was 48 h. Complete recovery in the total group of 140 patients was 87%. When 30 patients with low probability of DCS were excluded, the recovery rate was 98%. All patients with cerebral symptoms recovered. Patients with the highest severity scores showed a high rate of complete recovery (97.5%). DISCUSSION: Short oxygen treatment tables as originally described by Hart are effective in the treatment of DCS, even with long delays to definitive recompression that often occur among civilian divers presenting to a major Divers Alert Network referral center.

Entities:  

Mesh:

Year:  2006        PMID: 17042243

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  11 in total

1.  Prognostic factors of spinal cord decompression sickness in recreational diving: retrospective and multicentric analysis of 279 cases.

Authors:  Jean-Eric Blatteau; E Gempp; O Simon; M Coulange; B Delafosse; V Souday; G Cochard; J Arvieux; A Henckes; P Lafere; P Germonpre; J-M Lapoussiere; M Hugon; P Constantin; A Barthelemy
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

Review 2.  In-water recompression.

Authors:  David J Doolette; Simon J Mitchell
Journal:  Diving Hyperb Med       Date:  2018-06-30       Impact factor: 0.887

3.  A prospective single-blind randomised clinical trial comparing two treatment tables for the initial management of mild decompression sickness.

Authors:  Neil Banham; Philippa Hawkings; Ian Gawthrope
Journal:  Diving Hyperb Med       Date:  2022-06-30       Impact factor: 1.228

4.  Decompression Illness Treated with the Hart-Kindwall Protocol in a Monoplace Chamber.

Authors:  Yoshiaki Inuzuka; Naoki Edo; Yuichi Araki; Takafumi Hoshi; Mayuko Maruta; Nana Nakamoto; Shinya Suzuki
Journal:  Am J Case Rep       Date:  2022-06-12

Review 5.  Monoplace chamber treatment of decompression illness: Review and commentary.

Authors:  Richard Clarke
Journal:  Diving Hyperb Med       Date:  2020-09-30       Impact factor: 0.887

6.  Decompression syndrome (Caisson disease) in an Indian diver.

Authors:  Uday A Phatak; Eric J David; Pravin M Kulkarni
Journal:  Ann Indian Acad Neurol       Date:  2010-07       Impact factor: 1.383

7.  Factors influencing the severity of long-term sequelae in fishermen-divers with neurological decompression sickness.

Authors:  Jean-Eric Blatteau; Kate Lambrechts; Jean Ruffez
Journal:  Diving Hyperb Med       Date:  2020-03-31       Impact factor: 0.887

8.  A Delphi study to develop practical diagnostic guidelines for visual stress (pattern-related visual stress).

Authors:  Bruce J W Evans; Peter M Allen; Arnold J Wilkins
Journal:  J Optom       Date:  2016-11-24

9.  Oxygen toxicity seizures during United States Navy Treatment Table 6: An acceptable risk in monoplace chambers?

Authors:  Samantha Bonnington; Neil Banham; Kevin Foley; Ian Gawthrope
Journal:  Diving Hyperb Med       Date:  2021-06-30       Impact factor: 1.228

Review 10.  A systematic review of controlled trials on visual stress using Intuitive Overlays or the Intuitive Colorimeter.

Authors:  Bruce J W Evans; Peter M Allen
Journal:  J Optom       Date:  2016-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.